Aurobindo Pharma informs about analyst call

05 Aug 2019

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that an analyst / investor call on the Unaudited Financial Results of the Company for the first quarter ended 30th June 2019 is scheduled on 8th August 2019 at 8:30 AM.

The above information is a part of company’s filings submitted to BSE.

Related Aurobindo Pharma Ltd. Links:

Aurobindo Pharma Share Price

991.50 -1.45 (-0.15%) Apr 23, 10:05
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 643.40
Dr. Reddys Lab 5218.20
Lupin 1052.05
Piramal Enterprises 1657.05
Cadila Healthcare 557.95
View more..
Sensex vs Aurobindo Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323